![](https://ml.globenewswire.com/media/3839534a-6b19-42b9-8ca9-2def0a36b369/small/skye-logo-png.png)
Skye Bioscience Reports Second Quarter 2024 Financial Results and Recent Highlights
SAN DIEGO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ: SKYE) (“Skye” or the “Company”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today reported financial results for …